AVGO vs IBRX · P/E 87, rev $41.50B vs rev $51.2M
Broadcom Inc (AVGO) versus Immunitybio Inc (IBRX) — a side-by-side from cached financials, not a winner call.
Broadcom Inc (AVGO) is a semiconductors company listed on US. It is led by Hock Tan.
Immunitybio Inc (IBRX) is a biotechnology company listed on US.
Latest reported AVGO revenue for 2026-05-03 was $41.50B. Net income was $16.66B. AVGO currently screens at market cap $2.12T and trailing P/E 86.9.
Latest reported IBRX revenue for 2026-06-30 was $51.2M. Net income was -$230.4M. Revenue was up 15.9% from 2026-03-31 to 2026-06-30. IBRX currently screens at market cap $7.88B.
AVGO currently screens at market cap $2.12T and trailing P/E 86.9. IBRX currently screens at market cap $7.88B.
Not investment advice. Open the AVGO and IBRX stock pages for the full models.
Not investment advice.